Compass Therapeutics, Inc.
CMPXNasdaqCIK 1738021HealthcareFiscal year ends Dec 31
Reports and events: 112 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2020-06-2922:27 ET | SC 13D | Ownership report, active investor | 0000947871-20-000594 |
| 2020-06-2619:56 ET | SC 13D | Ownership report, active investor | 0001213900-20-015941 |
| 2020-06-2618:53 ET | SC 13D | Ownership report, active investor | 0001213900-20-015927 |
| 2020-06-2321:15 ET | 8-K | 1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 4.01 Change of auditor; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.06 Item not in the standard list; 9.01 Financial statements and exhibits | 0001213900-20-015594 |
| 2020-06-0820:34 ET | 10-K | Annual reportPeriod 2020-03-31 | 0001213900-20-014390 |
| 2020-02-1422:46 ET | 10-Q | Quarterly reportPeriod 2019-12-31 | 0001213900-20-003689 |
| 2019-11-1322:25 ET | 10-Q | Quarterly reportPeriod 2019-09-30 | 0001213900-19-023231 |
| 2019-08-1321:27 ET | 10-Q | Quarterly reportPeriod 2019-06-30 | 0001213900-19-015578 |
| 2019-07-0118:50 ET | 10-K | Annual reportPeriod 2019-03-31 | 0001213900-19-011850 |
| 2019-02-1418:17 ET | 10-Q | Quarterly reportPeriod 2018-12-31 | 0001213900-19-002496 |
| 2018-11-1421:27 ET | 10-Q | Quarterly reportPeriod 2018-09-30 | 0001213900-18-015798 |
| 2018-08-1417:00 ET | 10-Q | Quarterly reportPeriod 2018-06-30 | 0001213900-18-010934 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.